{"id":"https://openalex.org/W4399851187","doi":"https://doi.org/10.1016/j.critrevonc.2024.104426","title":"Evolving cancer resistance to anti-PD-1/PD-L1 antibodies in melanoma: Comprehensive insights with future prospects","display_name":"Evolving cancer resistance to anti-PD-1/PD-L1 antibodies in melanoma: Comprehensive insights with future prospects","publication_year":2024,"publication_date":"2024-06-20","ids":{"openalex":"https://openalex.org/W4399851187","doi":"https://doi.org/10.1016/j.critrevonc.2024.104426","pmid":"https://pubmed.ncbi.nlm.nih.gov/38908767"},"language":"en","primary_location":{"id":"doi:10.1016/j.critrevonc.2024.104426","doi":"https://doi.org/10.1016/j.critrevonc.2024.104426","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2024.104426","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.critrevonc.2024.104426","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001329664","display_name":"WenShao Li","orcid":"https://orcid.org/0009-0001-3036-0221","observed_orcids":["https://orcid.org/0009-0001-3036-0221"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenyu Li","raw_affiliation_strings":["Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101228182","display_name":"Junjie Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junjie Gu","raw_affiliation_strings":["Department of Urological Oncology, Peking University Cancer Hospital and Institute, Beijing, China","Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urological Oncology, Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]},{"raw_affiliation_string":"Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112945799","display_name":"Hongwei Fan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267179","display_name":"MSD (China) Investment Co., Ltd. (China)","ror":"https://ror.org/01hr8kn45","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267179"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongwei Fan","raw_affiliation_strings":["Value & Implementation, Global Medical & Scientific Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China","MRL Global Medical Affairs, MSD China, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value & Implementation, Global Medical & Scientific Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China","institution_ids":["https://openalex.org/I4405267179"]},{"raw_affiliation_string":"MRL Global Medical Affairs, MSD China, Shanghai, China","institution_ids":["https://openalex.org/I4405267179"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100425554","display_name":"Li Zhang","orcid":"https://orcid.org/0000-0002-3617-2627","observed_orcids":["https://orcid.org/0000-0002-3617-2627","https://orcid.org/0000-0003-2756-2620","https://orcid.org/0009-0001-8129-4308"]},"institutions":[{"id":"https://openalex.org/I4405267179","display_name":"MSD (China) Investment Co., Ltd. (China)","ror":"https://ror.org/01hr8kn45","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267179"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Li Zhang","raw_affiliation_strings":["Value & Implementation, Global Medical & Scientific Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China","MRL Global Medical Affairs, MSD China, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Value & Implementation, Global Medical & Scientific Affairs, Merck Sharp & Dohme (MSD) China, Shanghai, China","institution_ids":["https://openalex.org/I4405267179"]},{"raw_affiliation_string":"MRL Global Medical Affairs, MSD China, Shanghai, China","institution_ids":["https://openalex.org/I4405267179"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003905346","display_name":"Jun Guo","orcid":"https://orcid.org/0000-0002-2097-5054","observed_orcids":["https://orcid.org/0000-0002-2097-5054"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jun Guo","raw_affiliation_strings":["Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China; Department of Urological Oncology, Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: guoj307@126.com","Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China; Department of Urological Oncology, Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: guoj307@126.com","institution_ids":["https://openalex.org/I4210093964"]},{"raw_affiliation_string":"Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018372804","display_name":"Lu Si","orcid":"https://orcid.org/0000-0002-2123-9761","observed_orcids":["https://orcid.org/0000-0002-2123-9761"]},"institutions":[{"id":"https://openalex.org/I4210093964","display_name":"Peking University Cancer Hospital","ror":"https://ror.org/00nyxxr91","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093964"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Lu Si","raw_affiliation_strings":["Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: silu15_silu@126.com","Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: silu15_silu@126.com","institution_ids":["https://openalex.org/I4210093964"]},{"raw_affiliation_string":"Department of Melanoma and Sarcoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China","institution_ids":["https://openalex.org/I4210093964"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5003905346","https://openalex.org/A5018372804"],"corresponding_institution_ids":["https://openalex.org/I4210093964"],"apc_list":{"value":3690,"currency":"USD","value_usd":3690},"apc_paid":{"value":3690,"currency":"USD","value_usd":3690},"fwci":0.8843,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.7010333,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"201","issue":null,"first_page":"104426","last_page":"104426"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9670000076293945},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7279999852180481},{"id":"https://openalex.org/keywords/anti-pd-1-pd-l1-antibodies","display_name":"anti-PD-1/PD-L1 antibodies","score":0.8809999823570251},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.9459999799728394},{"id":"https://openalex.org/keywords/acral-melanoma","display_name":"acral melanoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/mucosal-melanoma","display_name":"mucosal melanoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-mutational-landscape","display_name":"tumor mutational landscape","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9929999709129333},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.8799999952316284},{"id":"https://openalex.org/keywords/resistance-epidemiology","display_name":"epidemiology of resistance","score":0.7009999752044678},{"id":"https://openalex.org/keywords/asian-populations","display_name":"Asian populations","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6742249727249146},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6422510147094727},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5794987082481384},{"id":"https://openalex.org/C57473165","wikidata":"https://www.wikidata.org/wiki/Q7315604","display_name":"Resistance (ecology)","level":2,"score":0.458198606967926},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4202045500278473},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40297362208366394},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3422107994556427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22740432620048523},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22134414315223694},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.07189485430717468}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.critrevonc.2024.104426","doi":"https://doi.org/10.1016/j.critrevonc.2024.104426","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2024.104426","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},{"id":"pmid:38908767","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38908767","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical reviews in oncology/hematology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.critrevonc.2024.104426","doi":"https://doi.org/10.1016/j.critrevonc.2024.104426","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.critrevonc.2024.104426","pdf_url":null,"source":{"id":"https://openalex.org/S185233701","display_name":"Critical Reviews in Oncology/Hematology","issn_l":"1040-8428","issn":["1040-8428","1879-0461"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews in Oncology/Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W1508084728","https://openalex.org/W2126932404","https://openalex.org/W2152897456","https://openalex.org/W2185075416","https://openalex.org/W2282089036","https://openalex.org/W2587048937","https://openalex.org/W2592262873","https://openalex.org/W2611187032","https://openalex.org/W2767533179","https://openalex.org/W2913383852","https://openalex.org/W2933124473","https://openalex.org/W2938667209","https://openalex.org/W2960092050","https://openalex.org/W2981494293","https://openalex.org/W3005546631","https://openalex.org/W3007548841","https://openalex.org/W3014748351","https://openalex.org/W3015496887","https://openalex.org/W3037333252","https://openalex.org/W3083135973","https://openalex.org/W3091934903","https://openalex.org/W3106910194","https://openalex.org/W3110468041","https://openalex.org/W3111836013","https://openalex.org/W3131231880","https://openalex.org/W3133991527","https://openalex.org/W3135125547","https://openalex.org/W3158438576","https://openalex.org/W3159504492","https://openalex.org/W3163284774","https://openalex.org/W3165102087","https://openalex.org/W3170127104","https://openalex.org/W3170590374","https://openalex.org/W3171006409","https://openalex.org/W3175895832","https://openalex.org/W3177071586","https://openalex.org/W3180697545","https://openalex.org/W3193127644","https://openalex.org/W3195875128","https://openalex.org/W3197265554","https://openalex.org/W3209571032","https://openalex.org/W3210866519","https://openalex.org/W4213183508","https://openalex.org/W4220663399","https://openalex.org/W4224237090","https://openalex.org/W4233897861","https://openalex.org/W4234835411","https://openalex.org/W4281657020","https://openalex.org/W4282944798","https://openalex.org/W4282980622","https://openalex.org/W4284896716","https://openalex.org/W4286602972","https://openalex.org/W4292063128","https://openalex.org/W4294100626","https://openalex.org/W4297339120","https://openalex.org/W4304698082","https://openalex.org/W4307707877","https://openalex.org/W4311310504","https://openalex.org/W4311584464","https://openalex.org/W4313406528","https://openalex.org/W4319985555","https://openalex.org/W4320482535","https://openalex.org/W4323545284","https://openalex.org/W4324139686","https://openalex.org/W4377107185","https://openalex.org/W4379280868","https://openalex.org/W4381612727","https://openalex.org/W4382751273","https://openalex.org/W4385197230","https://openalex.org/W4387811025","https://openalex.org/W4388058589","https://openalex.org/W6688141217"],"related_works":["https://openalex.org/W4394590273","https://openalex.org/W2903263827","https://openalex.org/W7214322937","https://openalex.org/W4382982501","https://openalex.org/W4224237090","https://openalex.org/W4284896716","https://openalex.org/W4407412647","https://openalex.org/W4304698082","https://openalex.org/W2607506177","https://openalex.org/W4412488244"],"abstract_inverted_index":{"Immunotherapy":[0],"has":[1,27],"transformed":[2],"the":[3,39,59,69,79,118,133],"treatment":[4,141],"of":[5,12,54,61,75,86,120,135],"advanced":[6],"melanoma.":[7,146],"However,":[8],"up":[9],"to":[10,22,56,63,102],"two-thirds":[11],"patients":[13,144],"experience":[14],"disease":[15],"progression":[16],"after":[17],"initially":[18],"achieving":[19],"a":[20],"response":[21],"immunotherapy.":[23],"Furthermore,":[24],"most":[25],"research":[26],"focused":[28],"on":[29,72],"cutaneous":[30],"melanoma":[31],"rather":[32],"than":[33],"acral":[34,88],"or":[35],"mucosal":[36,90],"melanoma,":[37],"although":[38],"latter":[40],"predominates":[41],"in":[42,139],"Asian":[43],"populations.":[44],"In":[45],"this":[46],"review,":[47],"we":[48,96],"examine":[49],"and":[50,58,83,89,105,109,126,137],"summarize":[51,106],"current":[52],"definitions":[53],"resistance":[55,62,101,121],"immunotherapy":[57,136],"epidemiology":[60],"PD-1":[64,103],"inhibition.":[65],"We":[66],"also":[67],"review":[68,97,114],"available":[70],"literature":[71],"molecular":[73],"mechanisms":[74],"resistance,":[76],"including":[77],"how":[78],"tumor":[80,84],"mutational":[81],"landscape":[82],"microenvironments":[85],"immunotherapy-resistant":[87],"melanomas":[91],"may":[92],"influence":[93],"resistance.":[94],"Finally,":[95],"strategies":[98],"for":[99,143],"overcoming":[100],"inhibition":[104],"completed":[107],"studies":[108],"ongoing":[110],"clinical":[111],"trials.":[112],"Our":[113],"highlights":[115],"that":[116],"improving":[117],"understanding":[119],"mechanisms,":[122],"optimizing":[123],"existing":[124],"therapies":[125],"further":[127],"studying":[128],"high-risk":[129],"populations":[130],"would":[131],"maximize":[132],"potential":[134],"result":[138],"optimized":[140],"outcomes":[142],"with":[145]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-06-21T00:00:00"}